Breaking News Instant updates and real-time market news.

2021-01-27 07:23:15 GLW Corning $37.18 / -1.28 (-3.33%) 07:23 01/27/21 01/27 07:23 01/27/21 07:23	Corning sees Q1 EPS 40c-44c, consensus 39c Sees core sales $3B-$3.2B, consensus $2.93B. CFO Tony Tripeny said, "In 2020, we successfully navigated a very challenging year. We strengthened our balance sheet, achieved growth in the second half, and generated free cash flow of $948M for the year. We expect year-over-year growth to accelerate in the first quarter of 2021. We expect core sales of $3B to $3.2B - compared with $2.5B in the first quarter last year - and EPS of 40c to 44c, which is double last year's first-quarter EPS at the low end of the range. We will continue to focus on operational excellence, cash-flow generation, and prudent capital allocation."	27 Jan 10 Feb
GLW Corning $37.18 / -1.28 (-3.33%) 01/14/21 Barclays Corning upgraded to Overweight with $44 target at Barclays 01/14/21 Barclays Corning upgraded to Overweight from Equal Weight at Barclays 01/06/21 Fly Intel: Top five analyst initiations 01/06/21 UBS Corning initiated with a Buy at UBS

2021-01-27 07:23:15

GLW

Corning

$37.18 / -1.28 (-3.33%)

07:23

01/27/21

01/27

07:23

01/27/21

07:23

Corning sees Q1 EPS 40c-44c, consensus 39c

Sees core sales $3B-$3.2B, consensus $2.93B. CFO Tony Tripeny said, "In 2020, we successfully navigated a very challenging year. We strengthened our balance sheet, achieved growth in the second half, and generated free cash flow of $948M for the year. We expect year-over-year growth to accelerate in the first quarter of 2021. We expect core sales of $3B to $3.2B - compared with $2.5B in the first quarter last year - and EPS of 40c to 44c, which is double last year's first-quarter EPS at the low end of the range. We will continue to focus on operational excellence, cash-flow generation, and prudent capital allocation."

27
Jan
10
Feb

GLW Corning

$37.18 / -1.28 (-3.33%)

01/14/21 Barclays: Corning upgraded to Overweight with $44 target at Barclays

01/14/21 Barclays: Corning upgraded to Overweight from Equal Weight at Barclays

01/06/21: Fly Intel: Top five analyst initiations

01/06/21 UBS: Corning initiated with a Buy at UBS

TODAY'S FREE FLY STORIES

Conference/Events	BlueLinx participates in a conference call with Benchmark » 12:59 03/08/21 03/08 12:59 03/08/21 12:59 BXC BlueLinx $36.00 / +1.13 (+3.24%) Building Products Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events BXC BlueLinx $36.00 / +1.13 (+3.24%) 02/12/21 Fly Intel: Top five analyst initiations 02/12/21 Benchmark BlueLinx initiated with a Buy at Benchmark 01/05/21 Craig-Hallum BlueLinx initiated with a Buy at Craig-Hallum 09/21/20 B. Riley FBR BlueLinx price target raised to $25 from $19 at B. Riley FBR 03/30/21 BlueLinx
Conference/Events	Truist pharmaceuticals analysts to hold an analyst/industry conference call » 12:55 03/08/21 03/08 12:55 03/08/21 12:55 LLY Eli Lilly $210.42 / +3.35 (+1.62%) Pharmaceuticals Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $210.42 / +3.35 (+1.62%) 03/05/21 EMA says bamlanivimab can be considered as monotherapy treatment for COVID-19 03/05/21 Eli Lilly research and development group publishes pirtobrutinib trial data 03/04/21 Eli Lilly announces results from SURPASS-2 clinical trial 03/03/21 Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint LLY Eli Lilly $210.42 / +3.35 (+1.62%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen LLY Eli Lilly $210.42 / +3.35 (+1.62%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $210.42 / +3.35 (+1.62%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $210.42 / +3.35 (+1.62%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $210.42 / +3.35 (+1.62%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Options	Put buyer takes advantage of recent oil rally » 12:50 03/08/21 03/08 12:50 03/08/21 12:50 USO United States Oil Fund $43.77 / -0.685 (-1.54%) Put buyer takes advantage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Periodicals Options USO United States Oil Fund $43.77 / -0.685 (-1.54%) 12/29/20 API crude inventories for week of December 21 USO United States Oil Fund $43.77 / -0.685 (-1.54%) 03/04/21 OPEC+ agrees to maintain oil output levels, Bloomberg reports 02/17/21 Saudis to raise oil output as prices recover, WSJ reports 01/05/21 OPEC+ reaches deal to hold oil output broadly steady, Bloomberg says 12/03/20 OPEC+ agrees on modest oil output increase from January, Reuters says USO United States Oil Fund $43.77 / -0.685 (-1.54%) 09:40 Today Unusually active option classes on open March 8th 01/05/21 Unusually active option classes on open January 5th 12/21/20 Unusually active option classes on open December 21st 12/10/20 Unusually active option classes on open December 10th
Hot Stocks	Chesapeake to pay $5.3M in restitution for Pennsylvania landowners » 12:49 03/08/21 03/08 12:49 03/08/21 12:49 CHK Chesapeake $43.81 / -1.19 (-2.64%) Pennsylvania Attorney… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options CHK Chesapeake $43.81 / -1.19 (-2.64%) 02/19/21 D.E. Shaw reports 7.3% passive stake in Chesapeake 12/17/20 Williams' resolution with Chesapeake receives bankruptcy court approval 11/23/20 Williams announces global resolution with Chesapeake CHK Chesapeake $43.81 / -1.19 (-2.64%) 02/17/21 Fly Intel: Top five analyst initiations 02/17/21 Wells Fargo Chesapeake initiated with an Overweight at Wells Fargo 07/22/20 Wells Fargo Crestwood Equity downgraded to Underweight at Wells Fargo 07/15/20 Morgan Stanley Williams upgraded to Overweight from Equal Weight at Morgan Stanley CHK Chesapeake $43.81 / -1.19 (-2.64%) 02/24/21 Thirteen new option listings on February 24th
Options	Macy's call volume above normal and directionally bullish » 12:45 03/08/21 03/08 12:45 03/08/21 12:45 M Macy's $16.26 / +1.14 (+7.54%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options M Macy's $16.26 / +1.14 (+7.54%) 03/01/21 Macy's eliminates COO role, appoints Laura Miller as Chief Information Officer 02/23/21 Macy's starting the year with 'really healthy' inventory 02/23/21 Macy's sees 1H21 'very similar' to 4Q20 02/23/21 Macy's testing off-mall concepts in Dallas, Atlanta, Washington DC M Macy's $16.26 / +1.14 (+7.54%) 02/24/21 Credit Suisse Macy's price target raised to $13 from $7 at Credit Suisse 02/24/21 Deutsche Bank Macy's price target raised to $16 from $15 at Deutsche Bank 02/18/21 Morgan Stanley Macy's price target raised to $11 from $6 at Morgan Stanley 01/21/21 Deutsche Bank Macy's price target raised to $15 from $9 at Deutsche Bank M Macy's $16.26 / +1.14 (+7.54%) 02/23/21 Macy's sees Q1 adjusted EPS (52c)-(45c), consensus (29c) 02/23/21 Macy's sees FY21 adjusted EPS 40c-90c, consensus 76c 02/23/21 Macy's reports Q4 adjusted EPS 80c, consensus 12c 02/22/21 Notable companies reporting before tomorrow's open M Macy's $16.26 / +1.14 (+7.54%) 02/28/21 Macy's, Gap letting customers buy now, pay later, WSJ reports 01/05/21 Macy's to close 45 department stores by mid-year, CNBC reports 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/14/20 Macy's converts two stores to fulfillment centers, Delaware News says M Macy's $16.26 / +1.14 (+7.54%) 03/01/21 Fly Insider: Cannae Holdings, Palantir among week's notable inside trades 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers M Macy's $16.26 / +1.14 (+7.54%) 03/01/21 Macy's call volume above normal and directionally bullish 01/28/21 Macy's call volume above normal and directionally bullish 01/28/21 Early notable gainers among liquid option names on January 28th 01/27/21 Early notable gainers among liquid option names on January 27th

Recommendations	Evonik price target raised to EUR 33 from EUR 28 at Societe Generale » 12:42 03/08/21 03/08 12:42 03/08/21 12:42 EVKIF Evonik $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EVKIF Evonik $0.00 / + (+0.00%) 12/07/20 Durect to sell Lactel product line to Evonik for $15M EVKIF Evonik $0.00 / + (+0.00%) 03/05/21 Credit Suisse Evonik price target raised to EUR 24 from EUR 22.50 at Credit Suisse 02/03/21 Barclays Evonik price target raised to EUR 30 from EUR 27 at Barclays 02/02/21 Baader Helvea Evonik downgraded to Add from Buy at Baader Helvea 01/20/21 HSBC Evonik downgraded to Reduce from Hold at HSBC
Recommendations	Vonovia price target raised to EUR 69 from EUR 68.10 at Societe Generale » 12:41 03/08/21 03/08 12:41 03/08/21 12:41 VNNVF Vonovia $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research VNNVF Vonovia $0.00 / + (+0.00%) 02/01/21 Barclays Vonovia price target raised to EUR 70 from EUR 65 at Barclays 01/28/21 DZ Bank Vonovia upgraded to Buy from Hold at DZ Bank 12/09/20 Societe Generale Vonovia initiated with a Buy at Societe Generale 11/19/20 Jefferies Vonovia upgraded to Buy from Hold at Jefferies
Recommendations	BASF price target raised to EUR 80 from EUR 78 at Societe Generale » 12:40 03/08/21 03/08 12:40 03/08/21 12:40 BASFY BASF $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BASFY BASF $0.00 / + (+0.00%) 03/01/21 Deutsche Bank BASF price target raised to EUR 88 from EUR 86 at Deutsche Bank 01/21/21 Barclays BASF price target raised to EUR 64 from EUR 60 at Barclays 01/21/21 Deutsche Bank BASF price target raised to EUR 86 from EUR 71 at Deutsche Bank 01/15/21 Berenberg BASF price target raised to EUR 74 from EUR 52 at Berenberg
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:40 03/08/21 03/08 12:40 03/08/21 12:40 MSFT Microsoft $230.50 / -1.1 (-0.47%) , SWI SolarWinds $16.26 / +0.13 (+0.81%) , ATH Athene Holding $52.05 / +3.2 (+6.55%) , APO Apollo Global $47.09 / -2.5 (-5.04%) , MCFE McAfee $24.20 / +2.95 (+13.88%) , GE General Electric $14.27 / +0.675 (+4.97%) , AER AerCap $58.76 / +7.93 (+15.60%) , MRK Merck $75.13 / +2.03 (+2.78%) , JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) , EYES Second Sight $11.51 / +5.82 (+102.28%) , GME GameStop $186.40 / +49.39 (+36.05%) , CHWY Chewy $80.05 / -2.76 (-3.33%) , ANAB AnaptysBio $19.35 / -10.09 (-34.27%) , GSX GSX Techedu $83.77 / -8.72 (-9.43%) Equity futures were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MSFT SWI ATH APO MCFE GE AER MRK JNJ EYES GME CHWY ANAB GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 11:20 Today European Commission approves Microsoft's ZeniMax acquisition 09:04 Today Intel, Microsoft to collaborate on DARPA program 03/07/21 Fly Intel: Top five weekend stock stories 03/05/21 Adaptive Biotechnologies says FDA issues EUA for T-Detect COVID SWI SolarWinds $16.26 / +0.13 (+0.81%) 03/05/21 Okta CEO: Really excited about the execution of the company 02/03/21 SolarWinds sees 'other additional attack vectors' continuing to come to light 01/06/21 DOJ says SolarWinds cyberattack affected its system 12/31/20 Microsoft says hackers viewed source code amid network intrusion ATH Athene Holding $52.05 / +3.2 (+6.55%) 09:47 Today Athene Holding rises 11.6% 07:04 Today Apollo to move to single share class, eliminate special governance rights 07:02 Today Apollo Global, Athene Holding to merge in all-stock transaction 02/16/21 Apollo Global, Athene Holding to sell AmeriHome Mortgage to Western Alliance APO Apollo Global $47.09 / -2.5 (-5.04%) 07:04 Today Apollo to move to single share class, eliminate special governance rights 07:02 Today Apollo Global, Athene Holding to merge in all-stock transaction 03/03/21 Apollo Global to acquire Michaels for $22.00 per share in cash 03/03/21 VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B MCFE McAfee $24.20 / +2.95 (+13.88%) 07:14 Today McAfee to sell enterprise business to STG-led consortium for $4B in cash 02/22/21 Intrusion appoints Gary Davis as CMO 12/10/20 McAfee declares 8.7c per share quarterly dividend 12/04/20 McAfee Chief Product Officer Ashutosh Kulkarni resigns effective January 1 GE General Electric $14.27 / +0.675 (+4.97%) 03/07/21 Fly Intel: Top five weekend stock stories 02/24/21 Altair acquires Flow Simulator sofftware from GE Aviation 02/17/21 General Electric focusing on growing through existing business lines, CEO says 02/17/21 General Electric CEO says unlikely to do large M&A deals soon AER AerCap $58.76 / +7.93 (+15.60%) 12:00 Today AerCap rises 16.1% 10:00 Today AerCap rises 12.5% 09:47 Today AerCap rises 14.2% 03/07/21 Fly Intel: Top five weekend stock stories MRK Merck $75.13 / +2.03 (+2.78%) 11:44 Today Merck presents results from Phase 1 trial of islatravir subdermal implant 03/07/21 Ridgeback, Merck announce findings from Phase 2a trial of COVID therapeutic 03/04/21 Merck begins tender offer to acquire Pandion Therapeutics for $60 per share 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 08:03 Today Iqvia collaborates with Janssen on COVID-19 vaccine clinical trials 03/05/21 Health Canada authorizes Janssen COVID-19 vaccine 03/04/21 Nemaura Medical appoints Alistair Longmuir as advisor on manufacture strategy 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine EYES Second Sight $11.51 / +5.82 (+102.28%) 03/05/21 Second Sight receives FDA approval for Argus 2s Retinal Prosthesis System 09/22/20 Second Sight resumes early feasibility study of Orion at UCLA GME GameStop $186.40 / +49.39 (+36.05%) 12:00 Today GameStop rises 26.4% 10:00 Today GameStop rises 10.8% 09:47 Today GameStop rises 17.3% 08:08 Today GameStop forms Strategic Planning and Capital Allocation Committee CHWY Chewy $80.05 / -2.76 (-3.33%) 02/03/21 GameStop appoints Matt Francis as CTO 01/19/21 Chewy CEO sells 127.8K shares of common stock 12/22/20 GameStop jumps over 25% after Chewy co-founder Cohen raises activist stake 12/15/20 Chewy's Star sells 30,000 class A common shares ANAB AnaptysBio $19.35 / -10.09 (-34.27%) 08:30 Today AnaptysBio trading resumes 08:02 Today AnaptysBio says imsidolimab POPLAR Phase 2 trial did not meet primary endpoint 07:55 Today AnaptysBio trading halted, news pending 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' GSX GSX Techedu $83.77 / -8.72 (-9.43%) 03/05/21 GSX Techedu rises 11.9% 03/05/21 GSX Techedu falls -16.6% 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% MSFT SWI ATH APO MCFE GE AER MRK JNJ EYES GME CHWY ANAB GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 10:20 Today BofA BofA says buy AMD and Nvidia as Steam data points to GPU upgrade tailwinds 09:55 Today Fly Intel: Top five analyst upgrades 07:33 Today Morgan Stanley Software industry rating raised to Attractive from In-Line at Morgan Stanley 06:53 Today Goldman Sachs Microsoft upgraded to Conviction Buy from Buy at Goldman Sachs SWI SolarWinds $16.26 / +0.13 (+0.81%) 03/03/21 Citi SolarWinds assumed with a Buy at Citi 02/23/21 Truist Palo Alto Networks price target raised to $425 from $385 at Truist 02/22/21 JMP Securities Pure Storage price target raised to $35 from $26 at JMP Securities 02/22/21 JMP Securities Crowdstrike price target raised to $295 from $180 at JMP Securities ATH Athene Holding $52.05 / +3.2 (+6.55%) 03/03/21 JPMorgan Athene Holding resumed with Overweight from Neutral at JPMorgan 02/18/21 Barclays Athene Holding price target raised to $50 from $48 at Barclays 01/20/21 Truist Athene Holding price target raised to $55 from $48 at Truist 01/08/21 Fly Intel: Top five analyst downgrades APO Apollo Global $47.09 / -2.5 (-5.04%) 03/03/21 Wells Fargo Michaels deal with Apollo Global 'a win for shareholders,' says Wells Fargo 03/03/21 Stifel Las Vegas Sands casino sale news 'clearly a positive,' says Stifel 01/20/21 Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo MCFE McAfee $24.20 / +2.95 (+13.88%) 10:38 Today Mizuho McAfee price target raised to $28 at Mizuho after enterprise security sale 02/24/21 Deutsche Bank Deutsche upgrades McAfee on 'best-in-class' consumer security unit 02/24/21 Mizuho McAfee price target raised to $26 from $25 at Mizuho 02/24/21 Citi McAfee price target raised to $21 from $18 at Citi GE General Electric $14.27 / +0.675 (+4.97%) 08:46 Today Stephens Stephens positive on AerCap reportedly buying GECAS 03/04/21 Morgan Stanley General Electric price target raised to $17 from $13 at Morgan Stanley 03/02/21 Barclays Danaher started at Overweight at Barclays on GE biopharma business potential 02/22/21 Goldman Sachs General Electric price target raised to $15 at Goldman Sachs after meetings AER AerCap $58.76 / +7.93 (+15.60%) 08:46 Today Stephens Stephens positive on AerCap reportedly buying GECAS 01/26/21 Cowen AerCap price target raised to $54 from $50 at Cowen 12/21/20 Deutsche Bank AerCap price target raised to $55 from $44 at Deutsche Bank 12/10/20 Barclays AerCap price target raised to $58 from $42 at Barclays MRK Merck $75.13 / +2.03 (+2.78%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' EYES Second Sight $11.51 / +5.82 (+102.28%) 04/01/20 H.C. Wainwright Second Sight rating placed under review at H.C. Wainwright GME GameStop $186.40 / +49.39 (+36.05%) 02/11/21 GLJ Research GLJ calls end to Reddit-driven Tilray rally, predicts 100% share downside 02/01/21 Mizuho Square benefited most from traders leaving Robinhood, says Mizuho 01/27/21 BofA With GameStop shares trading at $213.50, BofA raises price target to $10 01/25/21 KeyBanc Bed Bath & Beyond activity being driven by Reddit message board, says KeyBanc CHWY Chewy $80.05 / -2.76 (-3.33%) 01/28/21 Wells Fargo Chewy price target raised to $120 from $100 at Wells Fargo 01/19/21 Needham Chewy price target raised to $120 from $110 at Needham 01/19/21 UBS Chewy downgraded to Sell from Neutral at UBS 01/13/21 Credit Suisse Chewy price target raised to $121 from $104 at Credit Suisse ANAB AnaptysBio $19.35 / -10.09 (-34.27%) 12:11 Today JPMorgan JPMorgan double downgrades AnaptysBio back to Underweight after trial miss 12:04 Today JPMorgan AnaptysBio downgraded to Underweight from Overweight at JPMorgan 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan GSX GSX Techedu $83.77 / -8.72 (-9.43%) 09:02 Today Barclays GSX Techedu price target raised to $73 from $63 at Barclays 07:58 Today CLSA GSX Techedu downgraded to Sell from Outperform at CLSA 07:38 Today JPMorgan GSX Techedu price target lowered to $60 from $63 at JPMorgan 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan MSFT SWI ATH APO MCFE GE AER MRK JNJ GME CHWY ANAB GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B SWI SolarWinds $16.26 / +0.13 (+0.81%) 02/25/21 SolarWinds sees Q1 EPS 19c-20c, consensus 21c 02/25/21 SolarWinds reports Q4 EPS 26c, consensus 25c 10/27/20 SolarWinds sees 2020 EPS 98c, consensus 94c 10/27/20 SolarWinds sees Q4 EPS 25c, consensus 25c ATH Athene Holding $52.05 / +3.2 (+6.55%) 02/17/21 Athene Holding reports Q4 adjusted EPS $2.85, consensus $2.25 11/03/20 Athene Holding reports Q3 adj. EPS $1.53, consensus $1.10 APO Apollo Global $47.09 / -2.5 (-5.04%) 02/03/21 Apollo Global reports Q4 fee related EPS 63c, consensus 50c 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c MCFE McAfee $24.20 / +2.95 (+13.88%) 02/23/21 McAfee sees Q1 revenue $725M-$735M, consensus $724.42M 02/23/21 McAfee reports Q4 EPS (73c), consensus 31c 11/19/20 McAfee sees Q4 revenue $732M-$742M, consensus $728.2M 11/19/20 McAfee reports Q3 EPS breakeven, consensus 35c GE General Electric $14.27 / +0.675 (+4.97%) 01/26/21 General Electric sees FY21 adjusted EPS 15c-25c, consensus 38c 01/26/21 General Electric reports Q4 adjusted EPS 8c, consensus 9c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open AER AerCap $58.76 / +7.93 (+15.60%) 03/02/21 AerCap reports Q4 EPS 22c, consensus 94c 11/10/20 AerCap reports Q3 adjusted EPS $1.24, consensus $1.43 MRK Merck $75.13 / +2.03 (+2.78%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open GME GameStop $186.40 / +49.39 (+36.05%) 12/08/20 GameStop reports Q3 adj. EPS (53c), consensus (85c) 12/08/20 GameStop reports Q3 EPS (29c), consensus (85c) 12/08/20 Notable companies reporting after market close 09/09/20 GameStop reports Q2 adj. EPS ($1.40), consensus ($1.13) CHWY Chewy $80.05 / -2.76 (-3.33%) 12/08/20 Chewy raises FY20 revenue view to $7.04B-$7.06B from $6.775B-$6.825B 12/08/20 Chewy sees Q4 revenue $1.94B-$1.96B, consensus $1.79B 12/08/20 Chewy reports Q3 EPS (8c), consensus (13c) 12/08/20 Notable companies reporting after market close ANAB AnaptysBio $19.35 / -10.09 (-34.27%) 02/25/21 AnaptysBio reports Q4 EPS $1.20, consensus $1.39 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) GSX GSX Techedu $83.77 / -8.72 (-9.43%) 03/05/21 GSX Techedu sees Q1 revenue up 40%-43% versus last year 03/05/21 GSX Techedu reports Q4 EPS (39c), consensus (38c) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) 22 Oct 17 Sep 01 May MSFT SWI ATH APO GE AER MRK JNJ GME CHWY GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 03/07/21 Evolv going public in $1.7B SPAC merger, WSJ reports 03/07/21 White House urges action despite Microsoft patch amid active threat, Reuters says 03/05/21 30K U.S. groups hacked via Microsoft email software flaws, KrebsOnSecurity says 03/05/21 Take-Two CEO says players 'ready for $70 games,' VGC reports SWI SolarWinds $16.26 / +0.13 (+0.81%) 03/05/21 30K U.S. groups hacked via Microsoft email software flaws, KrebsOnSecurity says 02/23/21 Google lobbying Senate to press Microsoft on SolarWinds hack, Politico reports 02/02/21 China hackers broke into U.S. computers via SolarWinds flaw, Reuters reports 01/19/21 FireEye releases tool for auditing networks after SolarWinds hack, ZDNet says ATH Athene Holding $52.05 / +3.2 (+6.55%) 10/01/20 Athene, MassMutual made over $3B offer for American Equity, WSJ reports APO Apollo Global $47.09 / -2.5 (-5.04%) 03/05/21 Shutterfly in talks to merge with Altimar Acquisiton Corp. II, WSJ reports 03/01/21 Michaels attracting buyout interest from private equity players, NY Times says 03/01/21 Apollo, another firm interested in acquiring Michaels, NY Times reports 02/02/21 Apollo remains on UN watch list after Epstein report, FT says GE General Electric $14.27 / +0.675 (+4.97%) 03/07/21 GE nears deal to combine aircraft-leasing unit with AerCap, WSJ reports 02/16/21 General Electric sees negative cash flow in Q1, Reuters reports 02/11/21 Southwest in talks for at least 300 new 150-seat planes, Air Current says 01/14/21 GE says Siemens stole trade secrets in bid to rig contracts , Reuters reports AER AerCap $58.76 / +7.93 (+15.60%) 03/07/21 GE nears deal to combine aircraft-leasing unit with AerCap, WSJ reports MRK Merck $75.13 / +2.03 (+2.78%) 11:07 Today Biden to meet with CEOs of J&J, Merck at White House, Reuters reports 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 11:07 Today Biden to meet with CEOs of J&J, Merck at White House, Reuters reports 03/05/21 J&J COVID-19 vaccine approved by Canada's regulator, AP reports 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports GME GameStop $186.40 / +49.39 (+36.05%) 07:39 Today GameStop to pick Ryan Cohen to lead e-commerce shift, Bloomberg reports 02/25/21 Citron puts $50 target on Esports Entertainment, says GameStop should acquire 02/25/21 GameStop's Jim Bell forced to resign by the board, Business Insider reports 02/24/21 GameStop seeks CFO more in line with Cohen's vision, Bloomberg reports CHWY Chewy $80.05 / -2.76 (-3.33%) 07:39 Today GameStop to pick Ryan Cohen to lead e-commerce shift, Bloomberg reports 02/24/21 GameStop seeks CFO more in line with Cohen's vision, Bloomberg reports 01/16/21 GameStop stock double last week, challenges remain, Barron's says 11/16/20 Chewyco-founder Ryan Cohen wants 'tech-centric' makeover for GameStop, WSJ says GSX GSX Techedu $83.77 / -8.72 (-9.43%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says MSFT SWI ATH APO MCFE GE AER MRK JNJ EYES GME CHWY ANAB GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 11:08 Today Microsoft, Salesforce rise as analysts get more bullish on software sector 10:06 Today Microsoft, Target upgrades among today's top calls on Wall Street 03/04/21 Fly Intel: What to watch in Slack earnings report 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street SWI SolarWinds $16.26 / +0.13 (+0.81%) 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 12/23/20 Telos, Palo Alto seen among potential beneficiaries of Sunburst hack 12/23/20 Qualcomm initiation, IAC downgrade among today's top calls on Wall Street 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack ATH Athene Holding $52.05 / +3.2 (+6.55%) 09:06 Today Fly Intel: Pre-market Movers 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/01/20 Fly Intel: Wall Street's top stories at midday APO Apollo Global $47.09 / -2.5 (-5.04%) 09:06 Today Fly Intel: Pre-market Movers 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers MCFE McAfee $24.20 / +2.95 (+13.88%) 09:06 Today Fly Intel: Pre-market Movers 02/23/21 Fly Intel: After-Hours Movers 02/18/21 Wells Fargo, Seagate upgrades among today's top calls on Wall Street 11/19/20 Fly Intel: After-Hours Movers GE General Electric $14.27 / +0.675 (+4.97%) 09:06 Today Fly Intel: Pre-market Movers 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Pre-market Movers AER AerCap $58.76 / +7.93 (+15.60%) 09:06 Today Fly Intel: Pre-market Movers MRK Merck $75.13 / +2.03 (+2.78%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday EYES Second Sight $11.51 / +5.82 (+102.28%) 09:06 Today Fly Intel: Pre-market Movers GME GameStop $186.40 / +49.39 (+36.05%) 03/03/21 Rocket slides as analyst cuts rating following Reddit-fueled rally 03/02/21 Game On: GameStop CFO resigns, EA ceases new development on 'Anthem' 02/23/21 Fly Intel: After-Hours Movers 02/23/21 Game On: An exclusive talk with Skeleton Crew's Olsson and Murakami CHWY Chewy $80.05 / -2.76 (-3.33%) 12/08/20 Fly Intel: After-Hours Movers 11/16/20 Verizon resumption, Tapestry upgrade among today's top calls on Wall Street 10/16/20 Caterpillar upgrade among today's top calls on Wall Street 10/15/20 Fly Intel: After-Hours Movers ANAB AnaptysBio $19.35 / -10.09 (-34.27%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street GSX GSX Techedu $83.77 / -8.72 (-9.43%) 09:06 Today Fly Intel: Pre-market Movers 03/05/21 Fly Intel: Pre-market Movers 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 13:00 Today Biopharmaceuticals 03/12/21 Digital Media 04/09/21 Pharma/Biopharma 12/06/21 Software & Internet 00:00 Today Media, Internet and Telecom Virtual Conference 00:00 Today Global Healthcare Virtual Conference 2021 03/10/21 2nd Annual Enterprise Comms Virtual Summit 10:00 Today Microsoft - MSFT 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant 03/10/21 General Electric Co. MSFT APO MCFE GE MRK JNJ GME CHWY GSX MSFT Microsoft $230.50 / -1.1 (-0.47%) 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th 10/28/20 Notable open interest changes for October 28th APO Apollo Global $47.09 / -2.5 (-5.04%) 10/22/20 Apollo Global put volume heavy and directionally bearish MCFE McAfee $24.20 / +2.95 (+13.88%) 11/17/20 Three new option listings and three option delistings on November 17th GE General Electric $14.27 / +0.675 (+4.97%) 03/05/21 Notable open interest changes for March 5th 03/04/21 Early notable gainers among liquid option names on March 4th 02/24/21 General Electric call volume above normal and directionally bullish 01/26/21 Early notable gainers among liquid option names on January 26th MRK Merck $75.13 / +2.03 (+2.78%) 03/02/21 Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish JNJ Johnson & Johnson $158.51 / +2.42 (+1.55%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th GME GameStop $186.40 / +49.39 (+36.05%) 02/26/21 Gamestop trader lays out $200k for 2 hour calls struck 50% out of the money 02/26/21 Notable open interest changes for February 26th 02/24/21 Its Game on in GameStop as shares and implied volatility explode, again 02/05/21 Notable open interest changes for February 5th CHWY Chewy $80.05 / -2.76 (-3.33%) 02/08/21 Unusually active option classes on open February 8th 12/15/20 Chewy call volume above normal and directionally bullish 12/08/20 Chewy options imply 14.9% move in share price post-earnings 12/07/20 Unusually active option classes on open December 7th GSX GSX Techedu $83.77 / -8.72 (-9.43%) 09:55 Today GSX Techedu put volume heavy and directionally bearish 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish
General news	NY Fed's Survey of Consumer Expectations showed "sharp increases" » 12:40 03/08/21 03/08 12:40 03/08/21 12:40 NY Fed's Survey of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

General news	Investor Movement Index data reported » 12:36 03/08/21 03/08 12:36 03/08/21 12:36 February Investor… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Coca Cola call volume above normal and directionally bullish » 12:25 03/08/21 03/08 12:25 03/08/21 12:25 KO Coca-Cola $52.09 / +1.31 (+2.58%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options KO Coca-Cola $52.09 / +1.31 (+2.58%) 02/18/21 Coca-Cola increases quarterly dividend 2.4% to 42c per share 02/16/21 Berkshire Hathaway buys Verizon, exits Barrick Gold in Q4 02/14/21 Coca-Cola European Partners announces final offer to acquire Coca-Cola Amatil 02/10/21 Coca-Cola believes tax court 'misinterpreted and misapplied' in conclusions KO Coca-Cola $52.09 / +1.31 (+2.58%) 09:55 Today Fly Intel: Top five analyst upgrades 06:34 Today RBC Capital Coca-Cola upgraded to Outperform from Sector Perform at RBC Capital 05:25 Today RBC Capital Coca-Cola upgraded to Outperform from Sector Perform at RBC Capital 01/19/21 Bernstein Coca-Cola initiated with an Outperform at Bernstein KO Coca-Cola $52.09 / +1.31 (+2.58%) 02/10/21 Coca-Cola says Q1 adjusted EPS to include an approximate 2% currency headwind 02/10/21 Coca-Cola sees FY21 adjusted EPS growth high single digits to low double digits 02/10/21 Coca-Cola reports Q4 adjusted EPS 47c, consensus 42c 02/09/21 Notable companies reporting before tomorrow's open KO Coca-Cola $52.09 / +1.31 (+2.58%) 01/15/21 Coca-Cola won't run ads during Super Bowl, Variety reports 01/02/21 Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says 12/17/20 Coca-Cola reducing U.S. staff by 12%, cutting 2,200 jobs globally, WSJ reports KO Coca-Cola $52.09 / +1.31 (+2.58%) 10:06 Today Microsoft, Target upgrades among today's top calls on Wall Street 02/18/21 Fly Intel: Wall Street's top stories for Thursday 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 03/23/21 Coca-Cola 03/24/21 Coca-Cola 04/20/21 The Coca-Cola Company KO Coca-Cola $52.09 / +1.31 (+2.58%) 11/10/20 Coca Cola call volume above normal and directionally bullish 10/30/20 Coca Cola put volume heavy and directionally bearish 10/22/20 Unusually active option classes on open October 22nd
Conference/Events	Grupo Lala participates in a conference call with JPMorgan » 12:25 03/08/21 03/08 12:25 03/08/21 12:25 GRPBF Grupo Lala $0.00 / + (+0.00%) Mexico Consumer Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events GRPBF Grupo Lala $0.00 / + (+0.00%) 01/19/21 Barclays Grupo Lala upgraded to Overweight from Equal Weight at Barclays 12/03/20 Morgan Stanley Grupo Lala upgraded to Overweight from Underweight at Morgan Stanley 10/22/20 Barclays Grupo Lala upgraded to Equal Weight from Underweight at Barclays 10/15/20 Scotiabank Grupo Lala upgraded to Sector Perform from Underperform at Scotiabank 13:00 Today Grupo Lala - GRPBF
Conference/Events	Stephens electrical equipment analyst holds analyst/industry conference call » 12:25 03/08/21 03/08 12:25 03/08/21 12:25 GNRC Generac $303.82 / -3.8 (-1.24%) Electrical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GNRC Generac $303.82 / -3.8 (-1.24%) 02/19/21 Generac CMO sells 6.4K shares of common stock 01/19/21 Generac Power Systems establishes Energy Technology organization 11/10/20 Generac and Milwaukee World Festival announce new partnership 11/03/20 Generac Chairman Aaron Jagdfeld sold over $1M in company shares GNRC Generac $303.82 / -3.8 (-1.24%) 07:34 Today JPMorgan Generac price target lowered to $340 from $366 at JPMorgan 02/22/21 William Blair Three companies are well positioned for Texas rebuild, says William Blair 02/16/21 Stifel Generac price target raised to $340 from $213 at Stifel 02/12/21 JPMorgan Generac price target raised to $366 from $279 at JPMorgan GNRC Generac $303.82 / -3.8 (-1.24%) 02/11/21 Generac sees FY21 net sales growth 25%-30%, consensus $2.01B 02/11/21 Generac reports Q4 adjusted EPS $2.12, consensus $1.96 10/28/20 Generac raises 2020 revenue growth view to 10%-12% from 5%-8%, consensus $2.4B 10/28/20 Generac reports Q3 adjusted EPS $2.08, consensus $1.66 GNRC Generac $303.82 / -3.8 (-1.24%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 13:00 Today Electrical Equipment/Multi-Industry 03/15/21 33rd Annual Roth Virtual Conference 03/09/21 Generac
Conference/Events	Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 12:25 03/08/21 03/08 12:25 03/08/21 12:25 ADVM Adverum Biotechnologies $10.39 / -0.73 (-6.56%) , UBX Unity Biotechnology $6.35 / +0.2 (+3.25%) , AGTC Applied Genetic $4.78 / -0.1 (-2.05%) , JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) , MGTX MeiraGTx $14.60 / +0.21 (+1.46%) , NITE Nightstar Therapeutics $25.41 / + (+0.00%) , BIIB Biogen $276.63 / +5.67 (+2.09%) , AERI Aerie Pharmaceuticals $19.88 / +1.1 (+5.86%) , ALDX Aldeyra $11.00 / -0.17 (-1.52%) Biopharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Rumors Options ADVM UBX AGTC JNJ MGTX BIIB AERI ALDX ADVM Adverum Biotechnologies $10.39 / -0.73 (-6.56%) 03/01/21 Adverum Biotechnologies provides update on ADVM-022 clinical development path 02/22/21 Adverum appoints Reed Tuckson to board of directors 02/02/21 Adverum announces publication of safety data on ADVM-022 gene therapy 01/11/21 Adverum Biotechnologies announces 2021 focus areas UBX Unity Biotechnology $6.35 / +0.2 (+3.25%) 08:34 Today Unity Biotechnology appoints Alexander Nguyen as general counsel 02/24/21 Unity Biotechnology reports granting of employment inducement awards 02/08/21 Unity Biotechnology's UBX1325 shows eye disease treatment potential in study 02/03/21 Unity Biotechnology reports granting of employment inducement awards AGTC Applied Genetic $4.78 / -0.1 (-2.05%) 02/11/21 Applied Genetic expects cash, cash equivalents to fund programs into 2023 11/11/20 Applied Genetic reports additional data from Phase 1/2 trial in XLRP 10/07/20 Applied Genetic joins My Retina Tracker program as scientific collaborator 09/09/20 Applied Genetic on track for data readouts for ACHM program in Q4 JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 08:03 Today Iqvia collaborates with Janssen on COVID-19 vaccine clinical trials 03/05/21 Health Canada authorizes Janssen COVID-19 vaccine 03/04/21 Nemaura Medical appoints Alistair Longmuir as advisor on manufacture strategy 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine MGTX MeiraGTx $14.60 / +0.21 (+1.46%) 01/26/21 MeiraGTx granted fast track designation for AAV-CNGA3 11/13/20 MeiraGTx gene therapy demonstrates improvement in XLRP 10/04/20 MeiraGTx announces 9-month data from Phase 1/2 Trial of AAV-RPGR BIIB Biogen $276.63 / +5.67 (+2.09%) 03/04/21 Biogen to build gene therapy manufacturing center in North Carolina 03/04/21 Dyne Therapeutics appoints Wildon Farwell as CMO 02/03/21 Biogen sees FY21 adjusted R&D expense $2.35B-$2.45B 02/03/21 Biogen CEO sees 'a financial reset in 2021' AERI Aerie Pharmaceuticals $19.88 / +1.1 (+5.86%) 01/11/21 Aerie Pharmaceuticals receives EC marketing approval for Roclanda 11/13/20 Aerie Pharmaceuticals' Roclanda receives positive CHMP opinion in the EU 10/29/20 Aerie Pharmaceuticals initiates Phase 2b trial AR-15512 10/28/20 Aerie, Santen enter exclusive agreement for Rhopressa and Rocklatan in Japan ALDX Aldeyra $11.00 / -0.17 (-1.52%) 02/04/21 Aldeyra announces Phase 3 TRANQUILITY dry eye disease trial design 01/21/21 Aldeyra rises 6% after 1.37M share purchase disclosed by Perceptive Advisors 01/07/21 Aldeyra announces top-line results from run-in cohort in Tranquility study 12/22/20 Aldeyra confirms SARS-CoV-2 antiviral activity of ADX-1612 ADVM UBX AGTC JNJ MGTX NITE BIIB AERI ALDX ADVM Adverum Biotechnologies $10.39 / -0.73 (-6.56%) 12/15/20 UBS Adverum Biotechnologies initiated with a Neutral at UBS 11/15/20 Piper Sandler Adverum Biotechnologies shares should grind higher over time, says Piper Sandler 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform from Underperform at Raymond James 11/12/20 Raymond James Adverum Biotechnologies upgraded to Market Perform at Raymond James UBX Unity Biotechnology $6.35 / +0.2 (+3.25%) 02/16/21 Citi Unity Biotechnology downgraded to Sell from Neutral at Citi 08/18/20 Fly Intel: Top five analyst downgrades 08/18/20 Morgan Stanley Unity Biotechnology downgraded at Morgan Stanley as UBX101 doesn't meet endpoint 08/18/20 Citi Unity Biotechnology downgraded to Neutral from Buy at Citi AGTC Applied Genetic $4.78 / -0.1 (-2.05%) 03/01/21 Stifel Applied Genetic initiated with a Buy at Stifel 02/02/21 H.C. Wainwright Applied Genetic price target raised to $24 from $18 at H.C. Wainwright 02/01/21 Roth Capital Applied Genetic price target raised to $35 from $30 at Roth Capital 11/17/20 Roth Capital Applied Genetic price target raised to $30 from $26 at Roth Capital JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MGTX MeiraGTx $14.60 / +0.21 (+1.46%) 02/16/21 Chardan MeiraGTx called a Top Pick for 2021 at Chardan 12/17/20 Chardan Chardan boosts MeiraGTx target to $55, say buy shares 'now' 12/17/20 Piper Sandler Piper says MeiraGTx not getting credit for RIX gene therapy that 'clearly works' 10/22/20 RBC Capital MeiraGTx initiated with an Outperform at RBC Capital NITE Nightstar Therapeutics $25.41 / + (+0.00%) BIIB Biogen $276.63 / +5.67 (+2.09%) 02/17/21 Cantor Fitzgerald Biogen price target lowered to $268 from $278 at Cantor Fitzgerald 02/08/21 Citi Expert sees Biogen aducanumab approval 50/50 at best, says Citi 02/04/21 SVB Leerink Biogen price target lowered to $380 from $430 at SVB Leerink 02/04/21 Credit Suisse Biogen price target lowered to $338 from $350 at Credit Suisse AERI Aerie Pharmaceuticals $19.88 / +1.1 (+5.86%) 11/09/20 H.C. Wainwright Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright 10/28/20 H.C. Wainwright Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA 10/19/20 BofA Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA ALDX Aldeyra $11.00 / -0.17 (-1.52%) 02/08/21 H.C. Wainwright Aldeyra initiated with a Buy at H.C. Wainwright 01/28/21 JonesTrading Aldeyra assumed with a Buy at JonesTrading 01/08/21 Jefferies Aldeyra could double if topline of TRANQUILITY study positive, says Jefferies 01/08/21 Citi Aldeyra shares have 'plenty of upside' despite 26% rally, says Citi ADVM UBX AGTC JNJ MGTX BIIB AERI ALDX ADVM Adverum Biotechnologies $10.39 / -0.73 (-6.56%) 03/01/21 Adverum Biotechnologies reports Q4 EPS (39c), consensus (32c) 11/05/20 Adverum Biotechnologies reports Q3 EPS (31c), consensus (34c) UBX Unity Biotechnology $6.35 / +0.2 (+3.25%) 11/04/20 Unity Biotechnology reports Q3 EPS (52c), consensus (49c) AGTC Applied Genetic $4.78 / -0.1 (-2.05%) 02/11/21 Applied Genetic reports Q4 EPS (60c), consensus (59c) 11/16/20 Applied Genetic reports Q4 EPS (60c), consensus (53c) 09/09/20 Applied Genetic reports Q4 EPS (56c), consensus (48c) JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MGTX MeiraGTx $14.60 / +0.21 (+1.46%) 11/05/20 MeiraGTx reports Q3 EPS (17c), consensus (70c) 10/28/20 MeiraGTx to present data on phase 1/2 clinical trial on AAV-RPGR BIIB Biogen $276.63 / +5.67 (+2.09%) 02/03/21 Biogen sees FY21 adjusted EPS $17.00-$18.50, consensus $24.67 02/03/21 Biogen reports Q4 adjusted EPS $4.58, consensus $4.87 02/02/21 Notable companies reporting before tomorrow's open 02/02/21 Notable companies reporting before tomorrow's open AERI Aerie Pharmaceuticals $19.88 / +1.1 (+5.86%) 02/25/21 Aerie Pharmaceuticals reports Q4 EPS (79c), consensus (73c) 11/05/20 Aerie Pharmaceuticals reports Q3 EPS (86c), consensus (80c) ALDX Aldeyra $11.00 / -0.17 (-1.52%) 11/05/20 Aldeyra reports Q3 EPS (23c), consensus (27c) 28 Jan 14 Jan 19 Nov 13 Aug JNJ BIIB JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 11:07 Today Biden to meet with CEOs of J&J, Merck at White House, Reuters reports 03/05/21 J&J COVID-19 vaccine approved by Canada's regulator, AP reports 03/03/21 American, United to give J&J COVID-19 vaccine to Chicago workers, Reuters says 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports BIIB Biogen $276.63 / +5.67 (+2.09%) 11/07/20 Biogen Alzheimer's drug closer to approval, still not a buy, Barron's says 11/07/20 FDA may find it 'extremely' hard to approve Biogen drug after panel, STAT says 09/28/20 Biogen loses appeal in fight seeking royalties from Merck KGaA, Bloomberg says 09/28/20 Biogen loses appeal ruling on MS drug Rebif, Bloomberg says UBX AGTC JNJ BIIB AERI ALDX UBX Unity Biotechnology $6.35 / +0.2 (+3.25%) 09/16/20 Fly Intel: After-Hours Movers AGTC Applied Genetic $4.78 / -0.1 (-2.05%) 11/11/20 Hilton upgrade, AIG downgrade among today's top calls on Wall Street JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday BIIB Biogen $276.63 / +5.67 (+2.09%) 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 01/29/21 Fly Intel: Wall Street's top stories for Friday AERI Aerie Pharmaceuticals $19.88 / +1.1 (+5.86%) 10/19/20 Fly Intel: Wall Street's top stories for Monday 10/19/20 Fly Intel: Wall Street's top stories at midday 09/15/20 Fly Intel: Pre-market Movers ALDX Aldeyra $11.00 / -0.17 (-1.52%) 01/25/21 Fly Insider: OncoCyte, Air Transport among week's notable insider trades 01/21/21 Fly Intel: After-Hours Movers 13:00 Today Biopharmaceuticals 03/15/21 33rd Annual Roth Virtual Conference 03/16/21 31st Annual Healthcare Virtual Conference 03/11/21 Aldeyra - ALDX 04/20/21 Johnson & Johnson - JNJ 06/07/21 PDUFA Date for Aducanumab BIIB BIIB Biogen $276.63 / +5.67 (+2.09%) 09/15/20 Alexion strength attributed to takeover speculation JNJ BIIB JNJ Johnson & Johnson $158.45 / +2.355 (+1.51%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th BIIB Biogen $276.63 / +5.67 (+2.09%) 01/29/21 Early notable gainers among liquid option names on January 29th 01/08/21 Biogen put volume heavy and directionally bearish 11/11/20 Early notable gainers among liquid option names on November 11th 11/05/20 Unusually active option classes on open November 5th

Technical Analysis	NASDAQ market internals summary » 12:17 03/08/21 03/08 12:17 03/08/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/05/21 NASDAQ market internals summary 03/05/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 12:16 03/08/21 03/08 12:16 03/08/21 12:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/05/21 NYSE market internals summary 03/05/21 NYSE market internals summary
Hot Stocks	cbdMD announces court order staying California litigation » 12:15 03/08/21 03/08 12:15 03/08/21 12:15 YCBD cbdMD $3.75 / +0.1 (+2.74%) cbdMD announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options YCBD cbdMD $3.75 / +0.1 (+2.74%) 12/31/20 cbdMD to launch new products, announce partnerships next year, CEO says 12/31/20 cbdMD CEO sees having 'jump on competition' in U.K. market 12/31/20 cbdMD saw 'massive jump' in DTC business during pandemic, CEO says 12/31/20 cbdMD products now available for sale at all Life Time facilities, CEO says YCBD cbdMD $3.75 / +0.1 (+2.74%) 03/09/20 Cantor Fitzgerald cbdMD price target lowered to $1.20 from $3.40 at Cantor Fitzgerald YCBD cbdMD $3.75 / +0.1 (+2.74%) 02/09/21 cbdMD reports Q1 EPS (18c), two estimates (1c) 10/27/20 cbdMD reports preliminary Q4 Paw CBD revenue $1.6M-$1.65M 10/14/20 cbdMD sees Q4 revenue to increase 21%-23% YCBD cbdMD $3.75 / +0.1 (+2.74%) 02/09/21 Fly Intel: After-Hours Movers 12/31/20 Meet cbdMD: A Fly exclusive interview with co-CEO Martin Sumichrast 03/15/21 33rd Annual Roth Virtual Conference 03/12/21 cbdMD Inc YCBD cbdMD $3.75 / +0.1 (+2.74%) 12/22/20 cbdMD options imply 25.9% move in share price post-earnings
Recommendations	Paya Holdings Q4 shows bull thesis intact, says BTIG » 12:13 03/08/21 03/08 12:13 03/08/21 12:13 PAYA Paya Holdings $12.00 / +0.19 (+1.61%) This morning's Q4… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events PAYA Paya Holdings $12.00 / +0.19 (+1.61%) 03/02/21 Point72 Asset Management reports 5.5% passive stake in Paya Holdings 02/25/21 Paya's FIrst Billings Services, Agent 511 announce strategic partnership 02/09/21 Paya Holdings' payment solution certified by Acumatica 11/02/20 Paya Holdings appoints Matt Humphries as head of investor relations PAYA Paya Holdings $12.00 / +0.19 (+1.61%) 02/26/21 Raymond James Paya Holdings initiated with an Outperform at Raymond James 02/23/21 DA Davidson Paya Holdings initiated with a Buy at DA Davidson 02/23/21 DA Davidson Paya Holdings initiated with a Buy at DA Davidson 01/13/21 Fly Intel: Top five analyst initiations PAYA Paya Holdings $12.00 / +0.19 (+1.61%) 06:10 Today Paya Holdings sees FY21 revenue $234M-$242M, consensus $237.97M 06:09 Today Paya Holdings reports Q4 revenue $54M consensus $53.3M 11/09/20 Paya Holdings reports Q3 revenue $51.8M, consensus $53.35M 08:00 Today Paya Holdings - PAYA 03/23/21 Paya Holdings
Downgrade	JPMorgan double downgrades AnaptysBio back to Underweight after trial miss » 12:11 03/08/21 03/08 12:11 03/08/21 12:11 ANAB AnaptysBio $19.71 / -9.73 (-33.05%) , GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) JPMorgan analyst Anupam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events ANAB GSK ANAB AnaptysBio $19.71 / -9.73 (-33.05%) 08:30 Today AnaptysBio trading resumes 08:02 Today AnaptysBio says imsidolimab POPLAR Phase 2 trial did not meet primary endpoint 07:55 Today AnaptysBio trading halted, news pending 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) 03/03/21 Vir, GSK: DSMB recommends VIR-7831 arm of ACTIV-3 trial be closed to enrollment 03/02/21 Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX 02/24/21 J&J's Janssen announces submission of sNDA to FDA for expanded Cabenuva use 02/24/21 ViiV Healthcare submits sNDA to FDA for HIV treatment Cabenuva ANAB GSK ANAB AnaptysBio $19.71 / -9.73 (-33.05%) 12:04 Today JPMorgan AnaptysBio downgraded to Underweight from Overweight at JPMorgan 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan 10/27/20 Fly Intel: Top five analyst upgrades GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) 03/03/21 H.C. Wainwright Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright 02/12/21 Morgan Stanley GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley 02/11/21 Berenberg GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg 02/09/21 JPMorgan GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan ANAB GSK ANAB AnaptysBio $19.71 / -9.73 (-33.05%) 02/25/21 AnaptysBio reports Q4 EPS $1.20, consensus $1.39 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) 02/03/21 GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% GSK GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says ANAB GSK ANAB AnaptysBio $19.71 / -9.73 (-33.05%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street GSK GlaxoSmithKline $35.07 / +0.17 (+0.49%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/17/21 Fly Intel: Pre-market Movers 02/11/21 Fly Intel: Wall Street's top stories for Thursday 03/09/21 Global Consumer & Retail Virtual Conference 2021 03/16/21 31st Annual Healthcare Virtual Conference

Options	Deutsche Bank call volume above normal and directionally bullish » 12:05 03/08/21 03/08 12:05 03/08/21 12:05 DB Deutsche Bank $13.06 / +0.355 (+2.79%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options DB Deutsche Bank $13.06 / +0.355 (+2.79%) 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/04/20 Deutsche Bank, Google Cloud enter multi-year partnership 10/28/20 Deutsche Bank still sees FY20 provision for credit losses 35-45bps of loans DB Deutsche Bank $13.06 / +0.355 (+2.79%) 02/23/21 JPMorgan Deutsche Bank price target raised to EUR 9.60 from EUR 9 at JPMorgan 02/22/21 Berenberg Deutsche Bank price target raised to EUR 7 from EUR 5 at Berenberg 02/22/21 Barclays Barclays upgrades Deutsche Bank to Equal Weight on SPAC opportunity 02/22/21 Barclays Deutsche Bank upgraded to Equal Weight from Underweight at Barclays DB Deutsche Bank $13.06 / +0.355 (+2.79%) 02/04/21 Deutsche Bank reports Q4 group profit EUR 189M vs. (EUR 1.5B) last year 10/28/20 Deutsche Bank reports Q3 profit of EUR 309M, profit before tax EUR 482M DB Deutsche Bank $13.06 / +0.355 (+2.79%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 03/01/21 Deutsche Bank under pressure over sale of derivatives products in Spain, FT says 01/24/21 Deutsche starts probe in relation to engagement with some clients, FT says 01/12/21 Deutsche Bank won't do future business with Trump, NY Times reports DB Deutsche Bank $13.06 / +0.355 (+2.79%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 11/07/20 Week in review: How Trump's policies moved stocks 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday DB Deutsche Bank $13.06 / +0.355 (+2.79%) 03/04/21 Deutsche Bank call volume above normal and directionally bullish 03/03/21 Deutsche Bank call volume above normal and directionally bullish 10/29/20 Deutsche Bank put volume heavy and directionally bearish 10/26/20 Deutsche Bank call volume above normal and directionally bullish
General news	Treasury's $105 B 3- and 6-month bill auctions were well received » 12:05 03/08/21 03/08 12:05 03/08/21 12:05 Treasury's $105 B 3-… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	AnaptysBio downgraded to Underweight from Overweight at JPMorgan » 12:04 03/08/21 03/08 12:04 03/08/21 12:04 ANAB AnaptysBio $19.90 / -9.54 (-32.40%) JPMorgan analyst Anupam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ANAB AnaptysBio $19.90 / -9.54 (-32.40%) 08:30 Today AnaptysBio trading resumes 08:02 Today AnaptysBio says imsidolimab POPLAR Phase 2 trial did not meet primary endpoint 07:55 Today AnaptysBio trading halted, news pending 11/04/20 AnaptysBio sees net cash burn in FY20 'will be close to breakeven' ANAB AnaptysBio $19.90 / -9.54 (-32.40%) 02/11/21 JPMorgan JPMorgan double upgrades AnaptysBio, more than doubles price target 02/11/21 JPMorgan AnaptysBio upgraded to Overweight from Underweight at JPMorgan 10/27/20 Fly Intel: Top five analyst upgrades 10/27/20 Truist AnaptysBio price target raised to $27 from $20 at Truist ANAB AnaptysBio $19.90 / -9.54 (-32.40%) 02/25/21 AnaptysBio reports Q4 EPS $1.20, consensus $1.39 11/04/20 AnaptysBio reports Q3 EPS (87c), consensus (72c) ANAB AnaptysBio $19.90 / -9.54 (-32.40%) 02/11/21 Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street
Hot Stocks	SOS Limited falls -12.5% » 12:00 03/08/21 03/08 12:00 03/08/21 12:00 SOS SOS Limited $5.66 / -0.83 (-12.79%) SOS Limited is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals Options SOS SOS Limited $5.66 / -0.83 (-12.79%) 03/04/21 SOS Limited falls -8.7% 03/03/21 SOS Limited rises 16.5% 03/02/21 SOS Limited rises 15.2% 03/02/21 SOS Limited rises 16.4% SOS SOS Limited $5.66 / -0.83 (-12.79%) 09/22/20 SOS clarifies shares purchase price of Tripartite Agreement SOS SOS Limited $5.66 / -0.83 (-12.79%) 03/03/21 SOS rallies after Scorpio questions shorts, gives stock $40 valuation SOS SOS Limited $5.66 / -0.83 (-12.79%) 03/04/21 Largest borrow rate increases among liquid names 03/02/21 Unusually active option classes on open March 2nd 03/01/21 Largest borrow rate increases among liquid names 03/01/21 SOS Limited put buyer realizes 222% same-day gains
Hot Stocks	Cloopen falls -13.5% » 12:00 03/08/21 03/08 12:00 03/08/21 12:00 RAAS Cloopen $17.10 / -2.745 (-13.83%) Cloopen is down -13.5%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Syndicate On The Fly RAAS Cloopen $17.10 / -2.745 (-13.83%) 05:19 Today Citi Cloopen initiated with a Buy at Citi 03/06/21 Goldman Sachs Cloopen initiated with a Neutral at Goldman Sachs 09 Feb RAAS Cloopen $17.10 / -2.745 (-13.83%) 09:06 Today Fly Intel: Pre-market Movers 02/14/21 Opening Day: Bumble, Viant soar in market debuts

Events

Earnings calls, analyst events, roadshows and more

RAND
Today at 13:30

Rand Capital - RAND Conference Calls
Today at 14:00

Healthcare Industry Meetings
PRTH
Today at 16:00

Priority Technology - PRTH Conference Calls
CYDY
Today at 16:00

CytoDyn - CYDY Conference Calls
SNDX
Today at 16:30

Syndax - SNDX Conference Calls
CDMO
Today at 16:30

Avid Bioservices - CDMO Conference Calls
SIBN
Today at 16:30

SI-Bone - SIBN Conference Calls
FLL
Today at 16:30

Full House Resorts - FLL Conference Calls
CSTL
Today at 16:30

Castle Biosciences - CSTL Conference Calls
SMSI
Today at 16:30

Smith Micro - SMSI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	CPNG X CPNG Coupang IPO Managers: Goldman Sachs, Allen & Co., JPMorgan & BofA, HSBC, Deutsche Bank, UBS, MIZU, CLSA $27.00-30.00 120M Shares GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HAYW X HAYW Hayward IPO Managers: BofA, Goldman Sachs & Nomura, Credit Suisse, Morgan Stanley, Baird, Guggenheim, Jefferies, BMO Capital, KeyBanc, William Blair, HOUL, Moelis $17.00-19.00 40.278M Shares
Thurs	JOAN X JOAN Joann IPO Managers: BofA & Credit Suisse, Guggenheim, Barclays, Wells Fargo, Piper Sandler, William Blair, HOUL, Telsey Advisory, Loop Capital, Ramirez $15.00-17.00 10.94M Shares LBPH X LBPH Longboard Pharmaceuticals IPO Managers: Citi, Evercore ISI, Guggenheim & Cantor Fitzgerald $14.00-16.00 5M Shares OLO X OLO OLO IPO Managers: Goldman Sachs, JPMorgan & RBC Capital, Piper Sandler, Raine, Stifel, Truist, William Blair $15.00-18.00 18M Shares RXDX X RXDX Prometheus IPO Managers: SVB Leerink, Credit Suisse, Stifel & Guggenheim $16.00-18.00 7.35M Shares SNCY X SNCY Sun Country Airlines IPO Managers: Barclays, Morgan Stanley, Deutsche Bank, Goldman Sachs & Nomura, Apollo Global, AmeriVet, SIEB, Tribal $21.00-23.00 9.091M Shares
Fri	No deals

View All Syndicate Announcements »

Corning sees Q1 EPS 40c-44c, consensus 39c

TODAY'S FREE FLY STORIES

Get Full Fly Access